H
Hasan Khosravi
Researcher at University of Pittsburgh
Publications - 35
Citations - 357
Hasan Khosravi is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Teledermatology & Medicine. The author has an hindex of 9, co-authored 33 publications receiving 219 citations. Previous affiliations of Hasan Khosravi include Harvard University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Outcomes of Early Dermatology Consultation for Inpatients Diagnosed With Cellulitis.
David G. Li,Fan Di Xia,Hasan Khosravi,Anna K. Dewan,Daniel J. Pallin,Christopher W. Baugh,Karl Laskowski,Cara Joyce,Arash Mostaghimi +8 more
TL;DR: Early consultation by dermatologists for patients with presumed cellulitis represents a cost-effective intervention to improve health-related outcomes through the reduction of inappropriate antibiotic use and hospitalization.
Journal ArticleDOI
Immunomodulation by Schwann cells in disease.
Sophia Zhang,Galina V. Shurin,Hasan Khosravi,Rashek Kazi,Oleg Kruglov,Michael R. Shurin,Yuri L Bunimovich +6 more
TL;DR: This work highlights how Schwann cells may orchestrate an immunosuppressive tumor microenvironment by polarizing and modulating the activity of the dendritic cells.
Journal ArticleDOI
Ion-specific effects on prion nucleation and strain formation.
Jonathan Rubin,Hasan Khosravi,Kathryn L. Bruce,Megan E. Lydon,Sven Holger Behrens,Yury O. Chernoff,Andreas S. Bommarius +6 more
TL;DR: It is demonstrated that kosmotropes favor formation of amyloid strains that are characterized by lower thermostability and higher frangibility in vitro and stronger phenotypic and proliferation patterns effectively in vivo as compared with amyloids formed in chaotropes.
Journal ArticleDOI
BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid
Maryam Daneshpazhooh,Maryam Ghiasi,Vahideh Lajevardi,Nafise Nasiri,Kamran Balighi,Amir Teimourpour,Hasan Khosravi,Vahide Saeidi,Hamidreza Mahmoudi,Cheyda Chams-Davatchi +9 more
TL;DR: Both scoring systems demonstrated moderate validity and mucosal components did not show any correlation with anti-BP antibodies and are disproportionately presented in both BP scoring tools.
Journal ArticleDOI
Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma.
TL;DR: It is concluded that with a standardized clinical approach and training, dermatologists can pave the way in using T-VEC and future oncolytic virus therapies in appropriate clinical scenarios.